ARFIN vs MAXHEALTH: Stock Comparison
Head-to-head financial and trading comparison between Arfin India Limited (ARFIN) and Max Healthcare Institute Limited (MAXHEALTH) in the Cross-Sector Peers sector.
ARFIN
NSE: ARFINMAXHEALTH
NSE: MAXHEALTHKey Metrics Comparison Table
| Metric | ARFIN | MAXHEALTH | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹105.14 | ₹883.80 | — |
| 1-Year Price Return | +9.04% | -12.61% | ARFIN (21.65% higher) |
| 52-Week High | ₹107.52 | ₹1,153.40 | — |
| 52-Week Low | ₹82.06 | ₹873.40 | — |
| 30-Day Annualized Volatility | 57.5% | 31.96% | MAXHEALTH (Steadier) |
| 30-Day Average Daily Volume | 2,823,186 | 2,642,110 | ARFIN (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between ARFIN and MAXHEALTH, which stock gave better returns over the last year?
ARFIN has outperformed MAXHEALTH over the past 12 months with a gain of 9.04% compared to -12.61%.
Which stock is less volatile: ARFIN or MAXHEALTH?
MAXHEALTH demonstrated lower price volatility (31.96% annualized) compared to ARFIN (57.5%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of ARFIN vs MAXHEALTH?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are ARFIN and MAXHEALTH direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.